Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY-NC-ND 4.0Journal of Biological Engineering

Metabolic engineering of Saccharomyces cerevisiae for de novo biosynthesis of aesculin and cichoriin

4 affiliations
  1. 1School of Life Sciences, Institute of Life Sciences and Green Development, Hebei University, Baoding, Hebei 071002 China
  2. 2Engineering Laboratory of Microbial Breeding and Preservation of Hebei Province, Hebei University, Baoding, Hebei 071002 China
  3. 3Hebei Basic Science Center for Biotic Interaction, Hebei University, Baoding, Hebei 071002 China
  4. 4Engineering Research Center of Ecological Safety and Conservation in Beijing- Tianjin-Hebei (Xiong’an New Area) of MOE, Hebei University, Baoding, 071002 China

Abstract

Background: Coumarin glycosides are plant-derived polyphenols with diverse pharmacological activities and broad applications in the pharmaceutical, food and cosmetic industries. The low catalytic activity of 4CL and C2’H/F6’H, along with the poor stability of acyl-CoA and hydroxylated acyl-CoA intermediates, constitutes the major bottleneck for the conversion of phenolic acids to simple coumarins and limits yield improvement. Therefore, screening high-efficiency enzyme variants is critical for enhancing coumarin biosynthesis.

Results: In this study, we obtained the optimal combination Ptr4CL5‑AcF6’H1‑AtCOSY by screening esculetin synthases, which markedly enhanced the conversion efficiency of caffeic acid to esculetin, and we constructed a de novo biosynthetic pathway for esculetin. Multi-copy integration strengthened pathway flux and increased esculetin production by 87.67%. Heterologous expression of AcUGT92G7 and TOGT enabled the de novo biosynthesis of aesculin and cichoriin. Fine-tuning at the transcriptional and translational levels further optimized their titers, which reached 12.63 ± 0.31 mg/L and 8.51 ± 0.32 mg/L for aesculin and cichoriin, respectively. Meanwhile, pilot‑scale tests verified the feasibility of this strategy.

Conclusions: This study established de novo biosynthetic pathways for the two coumarin glycosides in S. cerevisiae, providing reliable strategies for efficient green biomanufacturing of coumarins and glycoside derivatives.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13036-026-00774-2.

Related

  1. Metabolic Engineering of Saccharomyces cerevisiae for Betulinic Acid Biosynthesis Reveals Pitfalls of Mitochondrial Compartmentalization of the Mevalonate Pathway
    Zhengqin Xu, Chengkai Zhang, Kangshun Yang +2
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
  2. Scp160 deletion suppresses TDP-43 aggregation and toxicity in Saccharomyces cerevisiae
    Microbial CellPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  3. Chemogenomic profiling of diverse Saccharomyces cerevisiae strains using the novel CRISPR-Cas9 markerless barcoded library BarMix
    Jackson Moore, Marjan Barazandeh, Corey Nislow +1
    Genome BiologyPeer-reviewedCC BY-NC-ND 4.0Molecular biology & gene regulationCrossref
  4. The Linker Histone Plays a Dual Role during Gametogenesis in Saccharomyces cerevisiae
    Jessica Bryant, Jérôme Govin, Liye Zhang +3
    Molecular and Cellular BiologyPeer-reviewedLicence not stated29 citedMolecular biology & gene regulationGeneral biologyHAL
  5. Engineered protein degradation of farnesyl pyrophosphate synthase is an effective regulatory mechanism to increase monoterpene production in Saccharomyces cerevisiae
    Bingyin Peng, Lars Nielsen, Sotirios Kampranis +1
    Metabolic EngineeringPeer-reviewedLicence not stated135 citedMolecular biology & gene regulationHAL
BibTeX
@article{pan2026metabolic,
  title = {{Metabolic engineering of Saccharomyces cerevisiae for de novo biosynthesis of aesculin and cichoriin}},
  author = {Shuai Pan and Boji Zhang and Qiming Wang},
  journal = {Journal of Biological Engineering},
  year = {2026},
  month = oct,
  doi = {10.1186/s13036-026-00774-2},
  url = {https://doi.org/10.1186/s13036-026-00774-2},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Metabolic engineering of Saccharomyces cerevisiae for de novo biosynthesis of aesculin and cichoriin
AU  - Shuai Pan
AU  - Boji Zhang
AU  - Qiming Wang
PY  - 2026
DA  - 2026/10/05
JO  - Journal of Biological Engineering
DO  - 10.1186/s13036-026-00774-2
UR  - https://doi.org/10.1186/s13036-026-00774-2
AB  - Background: Coumarin glycosides are plant-derived polyphenols with diverse pharmacological activities and broad applications in the pharmaceutical, food and cosmetic industries. The low catalytic activity of 4CL and C2’H/F6’H, along with the poor stability of acyl-CoA and hydroxylated acyl-CoA intermediates, constitutes the major bottleneck for the conversion of phenolic acids to simple coumarins and limits yield improvement. Therefore, screening high-efficiency enzyme variants is critical for enhancing coumarin biosynthesis.  Results: In this study, we obtained the optimal combination Ptr4CL5‑AcF6’H1‑AtCOSY by screening esculetin synthases, which markedly enhanced the conversion efficiency of caffeic acid to esculetin, and we constructed a de novo biosynthetic pathway for esculetin. Multi-copy integration strengthened pathway flux and increased esculetin production by 87.67%. Heterologous expression of AcUGT92G7 and TOGT enabled the de novo biosynthesis of aesculin and cichoriin. Fine-tuning at the transcriptional and translational levels further optimized their titers, which reached 12.63 ± 0.31 mg/L and 8.51 ± 0.32 mg/L for aesculin and cichoriin, respectively. Meanwhile, pilot‑scale tests verified the feasibility of this strategy.  Conclusions: This study established de novo biosynthetic pathways for the two coumarin glycosides in S. cerevisiae, providing reliable strategies for efficient green biomanufacturing of coumarins and glycoside derivatives.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13036-026-00774-2.
SN  - 1754-1611
ER  -